Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Nordic Capital sells its remaining shares in global medical products and technology company ConvaTec
May 3, 2018

Nordic Capital has sold its remaining shares in ConvaTec Group Plc. The remaining shareholding of 143,158,828 ordinary shares (representing approximately 7.3% of the issued share capital) in ConvaTec was sold on May 3, 2018, through a book-building process which generated strong investor interest. The price was 220 pence per ordinary share, raising gross proceeds of GBP 315 million.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: